Sign Up Today and Learn More About GRO Biosciences Stock
Invest in or calculate the value of your shares in GRO Biosciences or other pre-IPO companies through EquityZen's platform.
GRO Biosciences Stock (GROB)
GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.
About GRO Biosciences Stock
Founded
2016
Headquarters
Boston, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
GRO Biosciences Press Mentions
Stay in the know about the latest news on GRO Biosciences
GRO Biosciences Closes $60M Series B
vcnewsdaily • Aug 05, 2024
GRObio Secures $60.3 Million in Series B Financing to Advance Protein Therapeutics
synbiobeta • Aug 03, 2024
George Church Startup Nets $60M to Take Non-Standard Amino Acids to the Clinic
biospace • Aug 03, 2024
GRO Biosciences closes $60 million Series B financing
thepharmaletter • Jul 24, 2024
GRO Bio gathers $60M series B to take gout rival to Krystexxa into clinic
fiercebiotech • Jul 24, 2024
GRO Biosciences Management
Leadership team at GRO Biosciences
Co-Founder and Chief Executive Officer
Daniel J. Mandell
Co-Founder and Scientific Advisor
Ross Thyer
Join now and verify your accreditation status to gain access to:
- GRO Biosciences current valuation
- GRO Biosciences stock price
- Available deals in GRO Biosciences and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading GRO Biosciences Stock
How to invest in GRO Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like GRO Biosciences through EquityZen funds. These investments are made available by existing GRO Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell GRO Biosciences stock?
Shareholders can sell their GRO Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
